Company / PP&E (Net)
Twist Bioscience Corp PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$102.3M
FY2025
5-year range
$44.1M / $139.4M
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
#48 of 195
Health Care
What the data says
Twist Bioscience Corp's pp&e (net) of $102M is higher than 75% of companies in the Health Care sector (FY2025). PP&E (Net) has declined for 3 consecutive years, from $139M in FY2022 to $102M in FY2025.
Based on SEC 10-K filings.
$102M in FY2025 with a 5-year CAGR of +32.1%. Top quartile in the Health Care sector.
Declined from $132M to $102M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- +32.1%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 195This company $102.3M Sector average $770.1M
▼
-86.7% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of +32.1%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 0.2% year-over-year.
- Ranks #48 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $102.3M | -0.2% |
| FY2024 | $102.5M | -22.2% |
| FY2023 | $131.8M | -5.5% |
| FY2022 | $139.4M | +216.0% |
| FY2021 | $44.1M | +73.3% |
| FY2020 | $25.5M | +22.2% |
| FY2019 | $20.8M | +69.0% |
| FY2018 | $12.3M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026